Plasma soluble tumour necrosis factor-α receptor 2 is elevated in obesity: Specific contribution of visceral adiposity

Clinical Endocrinology

Volumn 72, Issue 3, 2010, Pages 349-357

  Cartier, Amélie ^a,b   Côté, Mélanie ^a,b   Bergeron, Jean ^c   Alméras, Natalie ^a   Tremblay, Angelo ^b   Lemieux, Isabelle ^a   Després, Jean Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY FAT; BODY MASS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROL GROUP; CONTROLLED STUDY; CORRELATIONAL STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; INTRAABDOMINAL FAT; MALE; OBESITY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; HOMEOSTASIS; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649131304     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03671.x     Document Type: Article

References (51)

1. Hotamisligil, G.S. Spiegelman, B.M. (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes, 43, 1271 1278.
2. Hotamisligil, G.S., Peraldi, P., Budavari, A. et al. (1996) IRS-1-Mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science, 271, 665 668.
3. Ruan, H. Lodish, H.F. (2003) Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Review, 14, 447 455.
4. Hotamisligil, G.S., Arner, P., Caro, J.F. et al. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation, 95, 2409 2415.
5. Kern, P.A., Saghizadeh, M., Ong, J.M. et al. (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Journal of Clinical Investigation, 95, 2111 2119.
6. Maeda, N., Shimomura, I., Kishida, K. et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine, 8, 731 737.
7. Kim, K.Y., Kim, J.K., Jeon, J.H. et al. (2005) c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes. Biochemical Biophysical Research Communications, 327, 460 467.
8. Van Gaal, L.F., Mertens, I.L. De Block, C.E. (2006) Mechanisms linking obesity with cardiovascular disease. Nature, 444, 875 880.
9. Ouchi, N., Kihara, S., Arita, Y. et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 102, 1296 1301.
10. Tartaglia, L.A., Weber, R.F., Figari, I.S. et al. (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. The Proceedings of the National Academy of Sciences of the U S A, 88, 9292 9296.
11. Smith, C.A., Farrah, T. Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76, 959 962.
12. Aderka, D., Engelmann, H., Maor, Y. et al. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. The Journal of Experimental Medicine, 175, 323 329.
13. Hotamisligil, G.S., Arner, P., Atkinson, R.L. et al. (1997) Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes, 46, 451 455.
14. Hauner, H., Bender, M., Haastert, B. et al. (1998) Plasma concentrations of soluble TNF-alpha receptors in obese subjects. International Journal of Obesity and Related Metabolic Disorders, 22, 1239 1243.
15. Liu, L.S., Spelleken, M., Rohrig, K. et al. (1998) Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes, 47, 515 522.
16. Fernandez- Real, J.M., Broch, M., Ricart, W. et al. (1998) Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes, 47, 1757 1762.
17. Conraads, V.M., Bosmans, J.M., Schuerwegh, A.J. et al. (2003) Association of lipoproteins with cytokines and cytokine receptors in heart failure patients. Differences between ischaemic versus idiopathic cardiomyopathy. European Heart Journal, 24, 2221 2226.
18. Behnke, A. Wilmore, J. (1974) Evaluation and Regulation of Body Build and Composition. Prentice-Hall, Englewood Cliffs, NJ.
19. Meneely, G. Kaltreider, N. (1949) Volume of the lung determined by helium dilution. Journal of Clinical Investigation, 28, 129 139.
20. Siri, W.E. (1956) The gross composition of the body. Advances in biological and medical physics, 4, 239 280.
21. Lohman, T., Roche, A. Martorell, R. (1988) Measurement descriptions and techniques. In : G. Steigelman ed. Anthropometric Standardisation Reference Manua. Human Kinetics Books, Champaign, IL, 1 71.
22. van der Kooy, K. Seidell, J.C. (1993) Techniques for the measurement of visceral fat: a practical guide. International Journal of Obesity and Related Metabolic Disorders, 17, 187 196.
23. Ferland, M., Després, J.P., Tremblay, A. et al. (1989) Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. British Journal of Nutrition, 61, 139 148.
24. Richterich, R. Dauwalder, H. (1971) [Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method]. Schweiz Medical Wochenschr, 101, 615 618.
25. Desbuquois, B. Aurbach, G.D. (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. Journal of Clinical Endocrinology and Metabolism, 33, 732 738.
26. Havel, R.J., Eder, H.A. Bragdon, J.H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation, 34, 1345 1353.
27. Burstein, M. Samaille, J. (1960) On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins. Clinica Chimica Acta, 5, 609.
28. Friedewald, W.T., Levy, R.I. Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499 502.
29. Ledue, T.B., Weiner, D.L., Sipe, J.D. et al. (1998) Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Annals of Clinical Biochemistry, 35 (Pt 6 745 753.
30. Corica, F., Allegra, A., Corsonello, A. et al. (1999) Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. International Journal of Obesity and Related Metabolic Disorders, 23, 355 360.
31. Bullo, M., Garcia-Lorda, P. Salas-Salvado, J. (2002) Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. European Journal of Endocrinology, 146, 325 331.
32. Bjorntorp, P. (1990) "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis, 10, 493 496. (Pubitemid 20220571)
33. Kissebah, A.H., Vydelingum, N., Murray, R. et al. (1982) Relation of body fat distribution to metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism, 54, 254 260.
34. Ronnemaa, T., Pulkki, K. Kaprio, J. (2000) Serum soluble tumor necrosis factor-alpha receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity. Journal of Clinical Endocrinology and Metabolism, 85, 2728 2732.
35. Hube, F., Birgel, M., Lee, Y.M. et al. (1999) Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation, 29, 672 678.
36. Mohamed-Ali, V., Goodrick, S., Bulmer, K. et al. (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. American Journal of Physiology, 277, E971 E975.
37. Vilarrasa, N., Vendrell, J., Sanchez-Santos, R. et al. (2007) Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clinical Endocrinology (Oxf), 67, 679 686.
38. Tartaglia, L.A., Pennica, D. Goeddel, D.V. (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. Journal of Biological Chemistry, 268, 18542 18548.
39. Kanety, H., Hemi, R., Papa, M.Z. et al. (1996) Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. Journal of Biological Chemistry, 271, 9895 9897.
40. Peraldi, P., Hotamisligil, G.S., Buurman, W.A. et al. (1996) Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. Journal of Biological Chemistry, 271, 13018 13022.
41. Aderka, D., Sorkine, P., Abu-Abid, S. et al. (1998) Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. Journal of Clinical Investigation, 101, 650 659.
42. Fernandez- Real, J.M., Lainez, B., Vendrell, J. et al. (2002) Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. American Journal of Physiology Endocrinology and Metabolism, 282, E952 E959.
43. Cseh, K., Winkler, G., Melczer, Z. et al. (2000) The role of tumour necrosis factor (TNF)-alpha resistance in obesity and insulin resistance. Diabetologia, 43, 525.
44. Shai, I., Schulze, M.B., Manson, J.E. et al. (2005) A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care, 28, 1376 1382. (Pubitemid 40756700)
45. DeFronzo, R.A., Ferrannini, E. Simonson, D.C. (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism, 38, 387 395.
46. Winzen, R., Wallach, D., Kemper, O. et al. (1993) Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. Journal of Immunology, 150, 4346 4353.
47. Lantz, M., Malik, S., Slevin, M.L. et al. (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine, 2, 402 406.
48. Tilg, H., Trehu, E., Atkins, M.B. et al. (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood, 83, 113 118.
49. Hajjar, D.P. Pomerantz, K.B. (1992) Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. Faseb Journal, 6, 2933 2941.
50. Fernandez- Real, J.M., Broch, M., Vendrell, J. et al. (2003) Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. International Journal of Obesity and Related Metabolic Disorders, 27, 1552 1556.
51. Hasday, J.D., Bascom, R., Costa, J.J. et al. (1999) Bacterial endotoxin is an active component of cigarette smoke. Chest, 115, 829 835.